Sysmex Stock

Sysmex Net Income 2024

Sysmex Net Income

49.64 B JPY

Ticker

6869.T

ISIN

JP3351100007

WKN

897966

In 2024, Sysmex's profit amounted to 49.64 B JPY, a 8.42% increase from the 45.78 B JPY profit recorded in the previous year.

The Sysmex Net Income history

YEARNET INCOME (undefined JPY)
2027e74.48
2026e65.95
2025e58.34
202449.64
202345.78
202244.09
202131.91
202034.88
201941.22
201839.22
201740.64
201639.28
201526.64
201420.57
201314.17
201212.01
201111.41
20109.76
20098.01
20089.13
20079.01
20067.26
20055.62

Sysmex Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Sysmex, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Sysmex from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Sysmex’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Sysmex. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Sysmex’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Sysmex’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Sysmex’s growth potential.

Sysmex Revenue, EBIT and net profit per share

DateSysmex RevenueSysmex EBITSysmex Net Income
2027e608.2 B undefined0 undefined74.48 B undefined
2026e557.93 B undefined0 undefined65.95 B undefined
2025e518.54 B undefined0 undefined58.34 B undefined
2024461.51 B undefined80.06 B undefined49.64 B undefined
2023410.5 B undefined73.99 B undefined45.78 B undefined
2022363.78 B undefined68.95 B undefined44.09 B undefined
2021305.07 B undefined49.86 B undefined31.91 B undefined
2020301.98 B undefined54.89 B undefined34.88 B undefined
2019293.51 B undefined61.43 B undefined41.22 B undefined
2018281.94 B undefined60.01 B undefined39.22 B undefined
2017249.9 B undefined51.92 B undefined40.64 B undefined
2016252.62 B undefined61.08 B undefined39.28 B undefined
2015221.38 B undefined44.41 B undefined26.64 B undefined
2014184.54 B undefined32.87 B undefined20.57 B undefined
2013145.58 B undefined21.8 B undefined14.17 B undefined
2012134.74 B undefined19.21 B undefined12.01 B undefined
2011124.69 B undefined18.29 B undefined11.41 B undefined
2010116.17 B undefined15.71 B undefined9.76 B undefined
2009111.84 B undefined14.79 B undefined8.01 B undefined
2008110.72 B undefined15.04 B undefined9.13 B undefined
2007101.04 B undefined12.72 B undefined9.01 B undefined
200687.89 B undefined10.72 B undefined7.26 B undefined
200576.93 B undefined9.03 B undefined5.62 B undefined

Sysmex stock margins

The Sysmex margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Sysmex. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Sysmex.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Sysmex's sales revenue. A higher gross margin percentage indicates that the Sysmex retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Sysmex's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Sysmex's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Sysmex's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Sysmex. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Sysmex's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Sysmex Margin History

Sysmex Gross marginSysmex Profit marginSysmex EBIT marginSysmex Profit margin
2027e52.54 %0 %12.25 %
2026e52.54 %0 %11.82 %
2025e52.54 %0 %11.25 %
202452.54 %17.35 %10.76 %
202352.64 %18.03 %11.15 %
202252.39 %18.95 %12.12 %
202150.58 %16.34 %10.46 %
202052.92 %18.18 %11.55 %
201955.06 %20.93 %14.05 %
201856.38 %21.29 %13.91 %
201756.73 %20.77 %16.26 %
201659.65 %24.18 %15.55 %
201556.92 %20.06 %12.03 %
201462.71 %17.81 %11.15 %
201361.13 %14.98 %9.73 %
201261.67 %14.25 %8.91 %
201162.8 %14.67 %9.15 %
201063.43 %13.52 %8.4 %
200963.18 %13.23 %7.16 %
200859 %13.58 %8.25 %
200756.95 %12.58 %8.92 %
200658.2 %12.19 %8.26 %
200557.36 %11.74 %7.3 %

Sysmex Aktienanalyse

What does Sysmex do?

Sysmex Corp is a Japanese company that has been a leading provider of diagnostic and analytical laboratory systems and solutions for the healthcare industry since its founding in 1968. The company is headquartered in Kobe, Japan and employs over 9,000 people worldwide. History: Sysmex was founded by a group of young scientists in Japan who wanted to develop an automated blood cell analysis system to improve the high workload of manual blood analysis at the time. The company began developing this system and brought it to market in 1972. Business model: Sysmex focuses on the development, production, and sale of diagnostic systems and solutions for medical laboratories around the world. The company specializes in hematology, hemoglobinopathy, hemostasis, urinalysis, immunology, clinical chemistry, and molecular biology. Divisions: Sysmex Corp is divided into three main business divisions: 1. Diagnostic Systems: This division includes hematology, hemoglobinopathy, hemostasis, urinalysis, immunology, clinical chemistry, and molecular biology systems. Sysmex is one of the world's leading providers of hematology analysis devices and also offers molecular biology systems for the diagnosis and monitoring of infectious diseases and cancer. 2. Information Solutions: This division offers software and IT solutions that support laboratory management and the integration of laboratory data to optimize analysis processes. The company also offers solutions for automating laboratory processes and managing laboratory inventory. 3. Life Science: This division focuses on the development of products for the life sciences, particularly cell analysis and imaging, as well as production, processing, and storage of cell cultures. Sysmex is also involved in the production of devices for harvesting mesenchymal stem cells from adipose tissue. Products: Sysmex offers a variety of products, including: - Hematology analysis devices for determining blood cell parameters such as RBC, WBC, HGB, HCT, and platelets. - Hemostasis systems for analyzing blood coagulation. - Molecular biology systems for the diagnosis and monitoring of infectious diseases and cancer. - Urinalysis systems for analyzing urine samples for chemical and microscopic parameters. - Immunology analysis devices for determining specific proteins and antibodies in the blood. - Clinical chemistry analysis devices for analyzing chemical parameters in blood samples. - Software and IT solutions for optimizing laboratory processes and management. - Cell analysis and imaging systems for investigating cell morphology and functions. - Devices for harvesting mesenchymal stem cells from adipose tissue. In summary, Sysmex Corp is a global leader in diagnostic and analytical laboratory systems and solutions for the healthcare industry. In its nearly 50-year history, the company has developed and produced a wide range of products that enable laboratories to perform fast and accurate disease diagnosis. The company has also expanded its business into other areas such as information solutions and the life sciences. Sysmex ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Sysmex's Profit Margins

The profit margins of Sysmex represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Sysmex's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Sysmex's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Sysmex's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Sysmex’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Sysmex stock

How much profit has Sysmex made this year?

Sysmex has made 49.64 B JPY this year.

How has the profit developed compared to last year?

The profit has increased by 8.42% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Sysmex publish its earnings?

Sysmex publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Sysmex?

The profits of Sysmex are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Sysmex?

You can learn more about the earnings of Sysmex by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Sysmex pay?

Over the past 12 months, Sysmex paid a dividend of 29 JPY . This corresponds to a dividend yield of about 0.92 %. For the coming 12 months, Sysmex is expected to pay a dividend of 28.62 JPY.

What is the dividend yield of Sysmex?

The current dividend yield of Sysmex is 0.92 %.

When does Sysmex pay dividends?

Sysmex pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Sysmex?

Sysmex paid dividends every year for the past 23 years.

What is the dividend of Sysmex?

For the upcoming 12 months, dividends amounting to 28.62 JPY are expected. This corresponds to a dividend yield of 0.91 %.

In which sector is Sysmex located?

Sysmex is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sysmex kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sysmex from 12/1/2024 amounting to 15 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Sysmex pay the last dividend?

The last dividend was paid out on 12/1/2024.

What was the dividend of Sysmex in the year 2023?

In the year 2023, Sysmex distributed 42.667 JPY as dividends.

In which currency does Sysmex pay out the dividend?

The dividends of Sysmex are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Sysmex

Our stock analysis for Sysmex Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sysmex Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.